1 / 9

Benzodiazepines and Z Drugs: The Hidden Story Action For Cumbria

Benzodiazepines and Z Drugs: The Hidden Story Action For Cumbria. Welcome and Scene Setting. Purpose of Today. By the end of the today we will have: Gained a clearer view about what is happening across Cumbria Agreed what needs to change

Pat_Xavi
Download Presentation

Benzodiazepines and Z Drugs: The Hidden Story Action For Cumbria

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Benzodiazepines and Z Drugs: The Hidden StoryAction For Cumbria Welcome and Scene Setting

  2. Purpose of Today • By the end of the today we will have: • Gained a clearer view about what is happening across Cumbria • Agreed what needs to change • Agreed who will take leadership roles to bring about the change Nigel Maguire, Director of Market Development, Cumbria PCT

  3. We’re Going to Hear About: • National programme for improving access to psychological therapies • Current approaches to ensuring best practice in benzodiazepine in primary care • Benzodiazepines and substance misuse • The PCT plans for improving mental health and emotional wellbeing • Most importantly, your views and commitment Nigel Maguire, Director of Market Development, Cumbria PCT

  4. Towards Early Intervention • Policy and resources have been focussed on people with the most complex needs • About to consult on significant changes to mental health services in Cumbria, under banner of Closer to Home. • The aim will be to redress the balance between services for people with severe and enduring mental illness, and that much larger number of people who are suffering from acute and chronic mental distress. • This will allow us to intervene upstream, preventing situations from getting worse, and helping people to avoid more illness and dependence on specialist services Nigel Maguire, Director of Market Development, Cumbria PCT

  5. Things to Consider We will reflect on: • The role of benzodiazepines within the Cumbrian healthcare system • The benefits and disbenefits of benzodiazepines as a form of treatment • The patterns of benzodiazepine prescribing and use in Cumbria • The availability of benzodiazepines through non prescribed sources and street leakage • What we are already doing to improve the local situation in prescribing Nigel Maguire, Director of Market Development, Cumbria PCT

  6. Some Possible Objectives • Ensure best practice in benzodiazepine prescribing is effectively managed • Ensure best practice in supporting individuals prescribed benzodiazepines is followed • Develop services to support individuals who with the support of their prescribing doctor wish to reduce or withdraw from the use of benzodiazepines • Reduce the availability and misuse of benzodiazepines from street leakage Nigel Maguire, Director of Market Development, Cumbria PCT

  7. Opportunity for Change • We have a wide range of stakeholders here, which reflects the concern about the use of benzodiazepines. • We are likely to have a wide range of views about the nature of our problems in Cumbria, and the possible solutions. • We need to bring together a range of solutions which in combination will have real impact Nigel Maguire, Director of Market Development, Cumbria PCT

  8. A special thanks to • Mr and Mrs Allan and Thelma Weatherburn • Dr Alan Cohen For their contribution to this event Nigel Maguire, Director of Market Development, Cumbria PCT

  9. BENZODIAZEPENES AND Z DRUGS: THE HIDDEN STORY ACTION FOR CUMBRIA Wednesday 30 January 2008 09:00 – 09:30 Arrival and Coffee 09:30 – 09:50 Chairman’s welcome and scene setting: Nigel Maguire, Director of Market Development Cumbria Primary Care Trust 09:50 Key-note Presentation: Improving Access to Psychological Therapies: Dr Alan Cohen, Senior Clinical Advisor in Primary Care, Care Services Improvement Partnership (CSIP) 10:20 Benzodiazepine Prescribing in Primary Care: Dr Jeff Rudman, Cumbria Primary Care Trust GP Prescribing lead 10:40 Coffee 11:00 – 11:30 Substance Misuse and Benzodiazepines: Dr. Neville Wright, Consultant Psychiatrist, Cumbria Partnership NHS Trust 11:30 – 11:45 Improving Mental Health and Well Being in Cumbria: Vernon Watson. Associate Director, Cumbria PCT 11:45 Group Discussion and Action planning *Best practice – how do we consistently apply everywhere the good practice we already have *Where are the gaps – what action needs to be taken *How and who will take action from here and how will we know if it is effective 12:45 Lunch 13:15 Summary and Close: Nigel Maguire Nigel Maguire, Director of Market Development, Cumbria PCT

More Related